litlas
ログインアカウント作成

Socrates E. Papapoulos

1979–2025 年に発表

113
論文数
23,922
被引用数
87
h 指数
112
i10 指数

被引用数

Socrates E. Papapoulos の年別被引用数1979 年: 被引用 1 件1980 年: 被引用 5 件1981 年: 被引用 6 件1982 年: 被引用 5 件1983 年: 被引用 6 件1984 年: 被引用 8 件1985 年: 被引用 6 件1986 年: 被引用 3 件1987 年: 被引用 8 件1988 年: 被引用 2 件1989 年: 被引用 5 件1990 年: 被引用 4 件1991 年: 被引用 13 件1992 年: 被引用 17 件1993 年: 被引用 21 件1994 年: 被引用 22 件1995 年: 被引用 38 件1996 年: 被引用 55 件1997 年: 被引用 61 件1998 年: 被引用 57 件1999 年: 被引用 59 件2000 年: 被引用 92 件2001 年: 被引用 107 件2002 年: 被引用 137 件2003 年: 被引用 162 件2004 年: 被引用 152 件2005 年: 被引用 149 件2006 年: 被引用 181 件2007 年: 被引用 179 件2008 年: 被引用 226 件2009 年: 被引用 184 件2010 年: 被引用 231 件2011 年: 被引用 250 件2012 年: 被引用 239 件2013 年: 被引用 214 件2014 年: 被引用 221 件2015 年: 被引用 163 件2016 年: 被引用 201 件2017 年: 被引用 168 件2018 年: 被引用 174 件2019 年: 被引用 518 件2020 年: 被引用 551 件2021 年: 被引用 429 件2022 年: 被引用 346 件2023 年: 被引用 230 件2024 年: 被引用 354 件2025 年: 被引用 186 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,988 件、この内訳の 26.5%イギリス: 引用元論文 671 件、この内訳の 8.9%中国: 引用元論文 519 件、この内訳の 6.9%イタリア: 引用元論文 332 件、この内訳の 4.4%オランダ: 引用元論文 319 件、この内訳の 4.3%カナダ: 引用元論文 316 件、この内訳の 4.2%オーストラリア: 引用元論文 314 件、この内訳の 4.2%ドイツ: 引用元論文 305 件、この内訳の 4.1%日本: 引用元論文 251 件、この内訳の 3.3%スイス: 引用元論文 246 件、この内訳の 3.3%フランス: 引用元論文 241 件、この内訳の 3.2%ベルギー: 引用元論文 176 件、この内訳の 2.3%
0%26.5%その他 24.4%

機関

分野

  • Medicine65%
  • Biochemistry, Genetics and Molecular Biology26.3%
  • Engineering3.4%
  • Immunology and Microbiology1.3%
  • Dentistry0.9%
  • Neuroscience0.6%
  • その他2.5%

トピック

  • Bone health and treatments12.9%
  • Bone health and osteoporosis research12.1%
  • Bone Metabolism and Diseases9.7%
  • Bone and Joint Diseases3.8%
  • Parathyroid Disorders and Treatments2.6%
  • Hip and Femur Fractures1.8%
  • その他57.1%

共著者

全論文

検索で開く
  1. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

    著者: Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi, Jacques P. Brown, Roland Chapurlat, Steven R. Cummings, E. J. Czerwiński, Astrid Fahrleitner‐Pammer, David L. Kendler, Kurt Lippuner, Jean‐Yves Reginster, Christian Roux, Jorge Malouf, Michelle N. Bradley, Nadia Daizadeh, Andrea Wang, Paula Dakin, Nicola Pannacciulli, David W. Dempster, Socrates E. Papapoulos - The Lancet Diabetes & Endocrinology 2017 被引用: 961

  2. Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

    著者: Elizabeth Shane, David B. Burr, Bo Abrahamsen, Robert A. Adler, Thomas D. Brown, Angela M. Cheung, Felicia Cosman, Jeffrey R. Curtis, Richard Dell, David W. Dempster, Peter R. Ebeling, Thomas A. Einhorn, Harry K. Genant, Piet Geusens, Klaus Klaushofer, Joseph M. Lane, Fergus McKiernan, Ross E. McKinney, Alvin Choong Meng Ng, Jeri W. Nieves, Regis J. O’Keefe, Socrates E. Papapoulos, Tet Sen Howe, Marjolein C. H. van der Meulen, Robert S. Weinstein, Michael P. Whyte - Journal of Bone and Mineral Research 2013 被引用: 2,118

  3. ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

    著者: Henry G. Bone, Felicia Cosman, Paul D. Miller, Gregory C. Williams, Gary Hattersley, Ming‐yi Hu, Lorraine A. Fitzpatrick, Bruce Mitlak, Socrates E. Papapoulos, René Rizzoli, Robin K. Dore, John P. Bilezikian, Kenneth G. Saag - The Journal of Clinical Endocrinology & Metabolism 2018 被引用: 201

  4. Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

    著者: Harry K. Genant, Cyrus Cooper, Gyula Poór, Ian Reid, George E. Ehrlich, J. A. Kanis, B. E. C. Nordin, Elizabeth Barrett‐Connor, Dennis M. Black, Jean‐Philippe Bonjour, Bess Dawson‐Hughes, P.D. Delmas, J. Dequeker, Sérgio Ragi Eis, C. Gennari, O Johnell, C. Conrad Johnston, E. M. C. Lau, Uri Liberman, Robert S. Lindsay, T. John Martin, Basel Masri, C. Mautalén, Pierre J. Meunier, Paul D. Miller, Ambrish Mithal, Hirotoshi Morii, Socrates E. Papapoulos, Anthony D. Woolf, Wei Yu, Nikolai Khaltaev - Osteoporosis International 1999 被引用: 786

  5. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    著者: Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, Henry G. Bone, Bente Langdahl, Kenneth G. Saag, Ian R. Reid, Douglas P. Kiel, Ilaria Cavallari, Marc P. Bonaca, Stephen D. Wiviott, Tobias De Villiers, Ling Xu, Kurt Lippuner, Toshitaka Nakamura, Jean‐Yves Reginster, Jose Adolfo Rodriguez-Portales, C. Roux, José Zanchetta, Cristiano A. F. Zerbini, Jeong‐Gun Park, KyungAh Im, Abby Cange, Laura T. Grip, Norman Heyden, Carolyn DaSilva, Dosinda Cohn, Rachid Massaad, Boyd B. Scott, Nadia Verbruggen, Deborah M. Gurner, Deborah L. Miller, Micki L Blair, Adam B. Polis, S. Aubrey Stoch, Arthur C. Santora, Antonio Lombardi, Albert Leung, Keith D. Kaufman, Marc S. Sabatine, C. Mautalén, Z. Man, José Zanchetta, C. Magaril, Philip N. Sambrook, Jean‐Yves Reginster, Piet Geusens, Stefan Goemaere, Ben Hur Albergaria, Cristiano A. F. Zerbini, Marise Lazaretti Castro, Luiz Henrique de Gregório, Румен Стоилов, Anna-Maria I Borissova, Kiril Hristov Hristozov, Nataliya Temelkova, Ivona Daskalova, Stefka I Kuzmanova, Daniela Yaneva-Bichovska, Anastas Batalov, Pablo Riedemann, José Adolfo Rodríguez Portales, Hai Tang, Han-min Zhu, Zhenlin Zhang, Aijun Chao, Yali Hu, Zhiming Liu, Ju-ming Lu, Ming-cai Qiu, Xin Gao, Shaofen Zhang, Ling Xu, Weibo Xia, Eryuan Liao, Wenying Yang, Wen Wu, Kerong Dai, Renming Hu, Hai Tang, Juan José Jaller, Francisco Cabal, José Fernando Molina, Carlos Curé, Hernan Yupanqui-Lozno, Philippe Chalem, John Londoño, Maurício Abello, Edgardo D Tobias, William Otero, Tatjana Nikolić, Blazenka Miskic, J Štěpán, Václav Vyskočil, Libor Novosád, Jan Slesinger, Pavel Novosad, Erika Vlckova, Ladislav Bortlík, Eva Dokoupilová ほか 313 名 - The Lancet Diabetes & Endocrinology 2019 被引用: 169

  6. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study

    著者: Eugène McCloskey, J. Rathi, S. Heijmans, Mark Blagden, Bernard Cortet, E. J. Czerwiński, Peyman Hadji, Juraj Payer, Kerry Palmer, Robert Stad, James O’Kelly, Socrates E. Papapoulos - Osteoporosis International 2020 被引用: 158

  7. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

    著者: Kenneth Poole, Rutger L. van Bezooijen, N. Loveridge, Herman A. Hamersma, Socrates E. Papapoulos, Clemens W.G.M. Löwik, J. Reeve - The FASEB Journal 2005 被引用: 962

  8. Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial

    著者: Athanasios D. Anastasilakis, Socrates E. Papapoulos, Stergios A. Pοlyzos, Natasha M. Appelman‐Dijkstra, Polyzois Makras - Journal of Bone and Mineral Research 2019 被引用: 153

  9. Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years

    著者: Nelson B. Watts, John T. Grbic, Neil Binkley, Socrates E. Papapoulos, Peter Butler, Xiang Yin, Antoniette Tierney, Rachel B. Wagman, Michael R. McClung - The Journal of Clinical Endocrinology & Metabolism 2019 被引用: 99

  10. Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

    著者: Rutger L. van Bezooijen, Bernard A.J. Roelen, Annemieke Visser, L. van der Wee-Pals, Edwin de Wilt, Marcel Karperien, Herman A. Hamersma, Socrates E. Papapoulos, Peter ten Dijke, Clemens W.G.M. Löwik - The Journal of Experimental Medicine 2004 被引用: 883

  11. The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation

    著者: Polyzois Makras, Natasha M. Appelman‐Dijkstra, Socrates E. Papapoulos, Sandra van Wissen, Elizabeth M. Winter, Stergios A. Pοlyzos, Maria P. Yavropoulou, Athanasios D. Anastasilakis - The Journal of Clinical Endocrinology & Metabolism 2021 被引用: 60

  12. Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis

    著者: Natasha M. Appelman‐Dijkstra, Socrates E. Papapoulos - Drugs 2015 被引用: 115

  13. Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway

    著者: Natasha M. Appelman‐Dijkstra, Socrates E. Papapoulos - Nature Reviews Endocrinology 2018 被引用: 78

  14. Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension

    著者: Socrates E. Papapoulos, Roland Chapurlat, Cesar Libanati, Maria Luisa Brandi, Jacques P. Brown, E. J. Czerwiński, Marc-Antoine Krieg, Z. Man, Dan Mellström, S. Radominski, Jean‐Yves Reginster, Heinrich Resch, Jose Andrés Román Ivorra, Christian Roux, Eric Vittinghoff, Matthew Austin, Nadia Daizadeh, Michelle N. Bradley, Andreas Grauer, Steven R. Cummings, Henry G. Bone - Journal of Bone and Mineral Research 2011 被引用: 344

  15. Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation

    著者: Martine Deckers, Marcel Karperien, Chris van der Bent, Takeyoshi Yamashita, Socrates E. Papapoulos, Clemens W.G.M. Löwik - Endocrinology 2000 被引用: 533

  16. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

    著者: Socrates E. Papapoulos, Kurt Lippuner, Christian Roux, Celia J. F. Lin, David L. Kendler, E. Michael Lewiecki, Maria Luisa Brandi, E. J. Czerwiński, Edward Franek, P. Lakatos, C. Mautalén, Salvatore Minisola, Jean‐Yves Reginster, S. Jensen, Nadia Daizadeh, A. Wang, Marc A. Gavin, Cesar Libanati, Rachel B. Wagman, Henry G. Bone - Osteoporosis International 2015 被引用: 277

  17. Prolonged Bisphosphonate Release after Treatment in Children

    著者: Socrates E. Papapoulos, Serge C.L.M. Cremers - New England Journal of Medicine 2007 被引用: 211

  18. Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A

    著者: Martine Deckers, Rutger L. van Bezooijen, Geertje van der Horst, Jakomijn Hoogendam, Chris van der Bent, Socrates E. Papapoulos, Clemens W.G.M. Löwik - Endocrinology 2002 被引用: 617

  19. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

    著者: Rutger L. van Bezooijen, Peter ten Dijke, Socrates E. Papapoulos, Clemens W.G.M. Löwik - Cytokine & Growth Factor Reviews 2005 被引用: 367

  20. Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial

    著者: John P. Bilezikian, Gary Hattersley, Bruce Mitlak, Ming‐yi Hu, Lorraine A. Fitzpatrick, Christine Dabrowski, Paul D. Miller, Socrates E. Papapoulos - Current Medical Research and Opinion 2019 被引用: 46

  21. Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial

    著者: Socrates E. Papapoulos, Henry G. Bone, Felicia Cosman, David W. Dempster, Michael R. McClung, Toshitaka Nakamura, José Fernando Molina Restrepo, Mary Bouxsein, Dosinda Cohn, Anne de Papp, Rachid Massaad, Arthur C. Santora - Journal of Bone and Mineral Research 2020 被引用: 26

  22. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

    著者: René Rizzoli, Nansa Burlet, David L. Cahall, Pierre D. Delmas, Erik Fink Eriksen, Dieter Felsenberg, John T. Grbic, Mats Jontell, Regina Landesberg, Andrea Laslop, Martina Wollenhaupt, Socrates E. Papapoulos, Orhan Sezer, Michael Sprafka, Jean‐Yves Reginster - Bone 2008 被引用: 221

  23. Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment

    著者: Athanasios D. Anastasilakis, Maria P. Yavropoulou, Polyzois Makras, G Sakellariou, Fotini Papadopoulou, Spyridon Gerou, Socrates E. Papapoulos - European Journal of Endocrinology 2017 被引用: 86

  24. Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates

    著者: B.C.J. Majoor, Socrates E. Papapoulos, P. D. S. Dijkstra, Marta Fiocco, Neveen A. T. Hamdy, Natasha M. Appelman‐Dijkstra - The Journal of Clinical Endocrinology & Metabolism 2019 被引用: 75